Four months af­ter im­ple­ment­ing new PhI­II safe­ty pro­to­col, or­gan trans­plant biotech re­ports pa­tient death

A Boston biotech look­ing to make or­gan trans­plants less dan­ger­ous is find­ing it­self in the midst of a se­ri­ous neg­a­tive pa­tient out­come.

An in­di­vid­ual died …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER